A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel i...

by Pietri, Elisabetta, Andreis, Daniele, Fabbri, Francesca, Menna, Cecilia, Schirone, Alessio, Kopf, Barbara, Rocca, Andrea, Amadori, Dino, De Giorgi, Ugo
Published in Oncologist (2015)

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

by De Giorgi, Ugo, Caroli, Paola, Burgio, Salvatore L., Menna, Cecilia, Conteduca, Vincenza, Bianchi, Emanuela, Fabbri, Francesca, Carretta, Elisa, Amadori, Dino, Paganelli, Giovanni, Matteucci, Federica
Published in Oncotarget (2014)

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study

by Mercatali, Laura, Ricci, Marianna, Scarpi, Emanuela, Serra, Patrizia, Fabbri, Francesca, Ricci, Rossana, Liverani, Chiara, Zanoni, Michele, Zoli, Wainer, Maltoni, Roberta, Gunelli, Erica, Amadori, Dino, Ibrahim, Toni
Published 2013

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

by Buttitta, Fiamma, Felicioni, Lara, Lorito, Alessia Di, Cortellini, Alessio, Irtelli, Luciana, Brocco, Davide, Marino, Pietro Di, Traisci, Donatella, D’Ostilio, Nicola, Paolo, Alessandra Di, Malorgio, Francesco, Assalone, Pasquale, Felice, Sonia Di, Fabbri, Francesca, Cianci, Giovanni, Tursi, Michele De, Marchetti, Antonio
Published in Oncotarget (2020)